| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/11/2009 | US7572470 Licorice extract for use as a medicament |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/06/2009 | WO2009096560A1 Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/06/2009 | WO2009096559A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | US20090197951 Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death |
| 08/06/2009 | US20090197934 Imidazolinylmethyl aryl sulfonamide |
| 08/06/2009 | US20090197933 Imidazolinylmethyl aryl sulfonamide |
| 08/06/2009 | US20090197932 Imidazolinylmethyl aryl sulfonamide |
| 08/06/2009 | US20090197931 Imidazolinylmethy aryl sulfonamide |
| 08/06/2009 | US20090197911 Lonidamine analogues and treatment of polycystic kidney disease |
| 08/06/2009 | US20090197900 Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
| 08/06/2009 | US20090197813 Methods for treating FSH related conditions with GnRH antagonists |
| 08/06/2009 | US20090197804 Methods and Compositions for the Prevention and Treatment of Kidney Disease |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2713679A1 Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/06/2009 | CA2713677A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 08/06/2009 | CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/05/2009 | EP2085383A1 Piperidine derivatives or salts thereof |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085091A1 Use of hydrochloric acid in manufacture of medicament for treating disease caused by fouling of transport tract |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP2083840A1 Improved treatment for benign prostatic hyperplasia |
| 08/05/2009 | EP1771458B1 N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1581274B1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/05/2009 | CN101496877A Chinese-medicine mixture for treating prostatitis |
| 08/05/2009 | CN101496864A Chinese medicament preparation for treating renal proteinuria and diabetic renal proteinuria and preparation method thereof |
| 08/05/2009 | CN101496837A 'Relingqing' chewable tablet and preparation method thereof |
| 08/05/2009 | CN101496577A Special diet and foodstuffs formula containing small peptide for patient with kidney disease |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100522984C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522235C Externally used medicine for treating anischuria and its preparation method |
| 08/05/2009 | CN100522230C Medicine for treating diabetes and hephrosis and its preparing method |
| 08/05/2009 | CN100522198C Prostatitis-treating capsule and its preparing method and quality control method |
| 08/05/2009 | CN100522170C Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/04/2009 | US7569701 Crystal form of 5-hydroxy-1-methylimidazolidin-2,4-dione |
| 08/04/2009 | US7569598 Isomerization; crystallization |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2347447C Buffered compositions for dialysis |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009074674A3 Trisubstituted piperidines as renin inhibitors |
| 07/30/2009 | WO2009061786A3 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 07/30/2009 | WO2009050228A3 Csf-1r inhibitors for treatment of cancer and bone diseases |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | CA2749985A1 Diagnostic and therapeutic uses of gelsolin in renal failure |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2081963A2 Methods for reducing phosphate absorption |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1278494B1 Device and method for treating urinary incontinence in females |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2315235C Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 07/28/2009 | CA2178592C Long-acting injection suspensions and a process for their preparation |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | US20090186947 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 07/23/2009 | US20090186939 Method of Treating Chronic Kidney Disease |
| 07/23/2009 | US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/23/2009 | US20090186850 Peritoneal dialysis method |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | DE102008005484A1 Induktion und Förderung der Arteriogenese Induction and promotion of arteriogenesis |
| 07/23/2009 | CA2712341A1 Sulfate salt prophylaxis and therapies |
| 07/22/2009 | EP2080757A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1392337B2 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1244455B1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |